Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.20.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2020
Accumulated Other Comprehensive Lossincome  
Summary of Shareholders Equity Warrants Outstanding

 

    Shares  
Outstanding at December 31, 2018     5,799  
Issued     -  
Exercised     (402 )
Tendered     -  
Expired     -  
Outstanding at December 31, 2019     5,397 *
Issued     -  
Exercised     (2,576 )**
Tendered     -  
Expired     (1,493 )
Outstanding at September 30, 2020     1,328 ***

 

* Weighted average exercise price for outstanding warrants is $0.62.
** Converted into approximately 1,737.4 thousand shares of common stock.
*** Weighted average exercise price for outstanding warrants is $0.55.
Schedule of Antidilutive Securities

 

    As of September 30,  
    2020     2019  
Stock options     22,260       16,859  
Preferred Stock and accrued dividend upon conversion     9,104       9,240  
Warrants     1,328       5,799  
Total     32,692       31,898